Soleno Therapeutics Inc (SLNO)

Apr 24, 2025

Piper Sandler raises Soleno Therapeutics stock target to $145 By Investing.com - Investing.com Nigeria

Apr 24, 2025

Apr 24, 2025

Soleno Therapeutics (SLNO) Price Target Boosted to $145 by Piper Sandler | SLNO Stock News - GuruFocus

Apr 24, 2025

Apr 23, 2025

Capnia Inc stock soars to 52-week high, hits $74.11 By Investing.com - Investing.com India

Apr 23, 2025

Apr 23, 2025

Capnia Inc stock soars to 52-week high, hits $74.11 - Investing.com Australia

Apr 23, 2025

Apr 23, 2025

Soleno Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 7, 2025, at 4:30 PM ET - The Manila Times

Apr 23, 2025

Apr 23, 2025

Soleno Therapeutics to Report First Quarter 2025 Financial - GlobeNewswire

Apr 23, 2025

Apr 23, 2025

Soleno Therapeutics Launches First-Ever Earnings Call: Key Details for Q1 2025 Financial Results - Stock Titan

Apr 23, 2025

Apr 19, 2025

How To Trade (SLNO) - news.stocktradersdaily.com

Apr 19, 2025

Apr 18, 2025

Soleno Therapeutics appoints CBIZ CPAs as new auditor By Investing.com - Investing.com Nigeria

Apr 18, 2025

Apr 18, 2025

Soleno Therapeutics appoints CBIZ CPAs as new auditor - Investing.com Australia

Apr 18, 2025

Apr 18, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 18, 2025

Apr 17, 2025

Franklin Resources Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Apr 17, 2025

Apr 14, 2025

Soleno launches Vykat xr for hyperphagia in Prader-Willi syndrome (SLNO:NASDAQ) - Seeking Alpha

Apr 14, 2025

Apr 14, 2025

Soleno Therapeutics launches FDA-approved PWS treatment By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved - MSN

Apr 14, 2025

Apr 14, 2025

Soleno Therapeutics launches FDA-approved PWS treatment - Investing.com

Apr 14, 2025

Apr 14, 2025

Soleno Therapeutics Announces VYKAT(TM) XR Launch - The Manila Times

Apr 14, 2025

Apr 14, 2025

Breakthrough PWS Treatment VYKAT XR Now Available: First-Ever FDA Approval for Rare Disease - Stock Titan

Apr 14, 2025

Apr 14, 2025

SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN

Apr 14, 2025

Apr 09, 2025

KLP Kapitalforvaltning AS Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Apr 09, 2025

Apr 08, 2025

Soleno Therapeutics (SLNO) Gains FDA Approval for Prader-Willi T - GuruFocus

Apr 08, 2025

Apr 05, 2025

SLNO Quantitative Stock Analysis - Nasdaq

Apr 05, 2025

Apr 03, 2025

Capnia Inc stock soars to 52-week high, hits $74 mark - Investing.com

Apr 03, 2025

Apr 03, 2025

Soleno therapeutics SVP sells $265,156 in stock By Investing.com - Investing.com India

Apr 03, 2025

Apr 02, 2025

Soleno therapeutics SVP sells $265,156 in stock - Investing.com

Apr 02, 2025

Apr 01, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Bhatnagar Anish Sells 699,095 Shares - MarketBeat

Apr 01, 2025

Apr 01, 2025

Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod - Investing.com

Apr 01, 2025

Apr 01, 2025

High Growth Tech Stocks To Watch In The US April 2025 - simplywall.st

Apr 01, 2025

Mar 31, 2025

Soleno Therapeutics CEO sells $35.3 million in stock By Investing.com - Investing.com Philippines

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics CEO sells $35.3 million in stock - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock By Investing.com - Investing.com Nigeria

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics exec sells shares worth $9.5 million By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Soleno therapeutics director Matthew Pauls sells $424,797 in stock By Investing.com - Investing.com Canada

Mar 31, 2025

Mar 31, 2025

Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock - Investing.com India

Mar 31, 2025

Mar 31, 2025

Soleno therapeutics director Matthew Pauls sells $424,797 in stock - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics exec sells $700,330 in stock - Investing.com India

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics CFO sells $4.88 million in stock - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics Executives and Director Sell Shares - TradingView

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics CCO sells shares worth $2.48m - Investing.com

Mar 31, 2025

Mar 31, 2025

Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock By Investing.com - Investing.com UK

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics CCO sells shares worth $2.48m By Investing.com - Investing.com UK

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics CFO sells $4.88 million in stock By Investing.com - Investing.com UK

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics Executives Sell Shares - TradingView

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics exec sells shares worth $9.5 million - Investing.com

Mar 31, 2025

Mar 31, 2025

Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock - Investing.com Australia

Mar 31, 2025